Prophylactic mastectomy: the Rotterdam experience

被引：12

作者：

van Geel, AN ^{[1
]}

机构：

[1] Univ Rotterdam Hosp, Erasmus Med Ctr Daniel den Hoed, Family Canc Clin, Dept Surg Oncol, NL-3075 EA Rotterdam, Netherlands

来源：

BREAST | 2003年 / 12卷 / 06期

关键词：

prophylactic mastectonny; hereditary breast cancer; breast reconstruction; IMMEDIATE BREAST RECONSTRUCTION; FAMILY-HISTORY; BILATERAL MASTECTOMY; BRCA2; MUTATION; CANCER; WOMEN; RISK; EFFICACY; SURVEILLANCE; SURGERY;

D O I：

10.1016/S0960-9776(03)00136-X

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The efficacy of prophylactic mastectomy (PM) depends on the ability to remove all breast tissue and a regular mastectomy is recommended. In our study population (n=112), 103 women (94%) have chosen for immediate breast reconstruction (IBR) with a silicone prosthesis placed in a subpectoral pocket. The median follow-up after IBR was 3.5 (range 1-7) years. These 103 patients underwent 193 PM with IBR: 90 bilateral and 13 unilateral. The median follow-up after IBR was 3.5 (range 1-7) years. In 163 IBRs (82%) no complications were observed. The most common late complication was capsular contracture, significantly more around prostheses placed in a previously irradiated area. No cases of breast cancer were found after PM at a mean follow-up of 2.9 years. After breast cancer a delayed ipsilateral PM and/or contralateral PM can be considered after a disease-free interval of 2 years, also taking into account the age of onset of the first breast cancer. The prognosis of breast cancer in BRCA2 mutation patients seems to be similar to that in sporadic cancer. The most striking result of PM is the decrease of anxiety of developing breast cancer and a negative impact on their sexual life. Therefore a time delay is necessary to allow women to fully address the issues involved in PM and IBR. (C) 2003 Elsevier Ltd. All rights reserved.

引用

页码：357 / 361

页数：5

共 21 条

[1] Family history of breast cancer and local recurrence after breast-conserving therapy [J].

Brekelmans, CTM ;

Voogd, AC ;

Botke, G ;

van Geel, BN ;

Rodrigus, P ;

Rutgers, EJT ;

Klijn, JGM ;

Coebergh, JW .

EUROPEAN JOURNAL OF CANCER, 1999, 35 (04) :620-626

[2] Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk [J].

Brekelmans, CTM ;

Seynaeve, C ;

Bartels, CCM ;

Tilanus-Linthorst, MMA ;

Meijers-Heijboer, EJ ;

Crepin, CMG ;

van Geel, AN ;

Menke, M ;

Verhoog, LC ;

van den Ouweland, A ;

Obdeijn, IM ;

Klijn, JGM .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (04) :924-930

[3]

BRESSER P, COMMUNICATION

[4] Morbidity of immediate breast reconstruction (IBR) after mastectomy by a subpectorally placed silicone prosthesis: the adverse effect of radiotherapy [J].

Contant, CME ;

van Geel, AN ;

van der Holt, B ;

Griep, C ;

Wai, RTJ ;

Wiggers, T .

EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2000, 26 (04) :344-350

[5] Clinical experience of prophylactic mastectomy followed by immediate breast reconstruction in women at hereditary risk of breast cancer (HB(O)C) or a proven BRCA1 and BRCA2 germ-line mutation [J].

Contant, CME ;

Menke-Pluijmers, MBE ;

Seynaeve, C ;

Meijers-Heijboer, EJ ;

Klijn, JGM ;

Verhoog, LC ;

Wai, RTJ ;

Eggermont, AMM ;

van Geel, AN .

EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2002, 28 (06) :627-632

[6] Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy [J].

Frost, MH ;

Schaid, DJ ;

Sellers, TA ;

Slezak, JM ;

Arnold, PG ;

Woods, JE ;

Petty, PM ;

Johnson, JL ;

Sitta, DL ;

McDonnell, SK ;

Rummans, TA ;

Jenkins, RB ;

Sloan, JA ;

Hartmann, LC .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (03) :319-324

[7] Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers [J].

Hartmann, LC ;

Sellers, TA ;

Schaid, DJ ;

Frank, TS ;

Soderberg, CL ;

Sitta, DL ;

Frost, MH ;

Grant, CS ;

Donohue, JH ;

Woods, JE ;

McDonnell, SK ;

Vockley, CW ;

Deffenbaugh, A ;

Couch, FJ ;

Jenkins, RB .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (21) :1633-1637

[8] Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer [J].

Hartmann, LC ;

Schaid, DJ ;

Woods, JE ;

Crotty, TP ;

Myers, JL ;

Arnold, PG ;

Petty, PM ;

Sellers, TA ;

Johnson, JL ;

McDonnell, SK ;

Frost, MH ;

Jenkins, RB .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (02) :77-84

[9] One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: Emotional impact of the test outcome and decisions on risk management (Surveillance or prophylactic surgery) [J].

Lodder, LN ;

Frets, PG ;

Trijsburg, RW ;

Meijers-Heijboer, EJ ;

Klijn, JGM ;

Seynaeve, C ;

van Geel, AN ;

Tilanus, MMA ;

Bartels, CCM ;

Verhoog, LC ;

Brekelmans, CTM ;

Burger, CW ;

Niermeijer, MF .

BREAST CANCER RESEARCH AND TREATMENT, 2002, 73 (02) :97-112

[10] Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer [J].

McDonnell, SK ;

Schaid, DJ ;

Myers, JL ;

Grant, CS ;

Donohue, JH ;

Woods, JE ;

Frost, MH ;

Johnson, JL ;

Sitta, DL ;

Slezak, JM ;

Crotty, TB ;

Jenkins, RB ;

Sellers, TA ;

Hartmann, LC .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (19) :3938-3943

← 1 2 3 →